Dentsply sirona inc. XRAY.US Overview
XRAY AI Analysis & Strategy
Browsing restrictions can be lifted for a fee.
XRAY Current Performance
0.25%
Dentsply sirona inc.
-2.38%
Avg of Sector
-0.30%
S&P500
XRAY Key Information
XRAY Revenue by Segments
Browsing restrictions can be lifted for a fee.
XRAY Net Income
Browsing restrictions can be lifted for a fee.
XRAY Cash Flow
Browsing restrictions can be lifted for a fee.
XRAY Profit Margin
Browsing restrictions can be lifted for a fee.
XRAY PE Ratio River
Browsing restrictions can be lifted for a fee.
XRAY Financial Forecast
Browsing restrictions can be lifted for a fee.
| Quarterly | EPS Forecast | QoQ | Max | Min |
|---|---|---|---|---|
| 2025Q1 | ||||
| 2025Q2 | ||||
| 2025Q3 | ||||
| 2025Q4 | ||||
| 2026Q1 |
XRAY Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | |||||||
| 2024Q4 | |||||||
| 2024Q3 | |||||||
| 2024Q2 | |||||||
| 2024Q1 |
XRAY Profile
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products. The Consumables segment offers endodontic products comprising drills, filers, sealers, irrigation needles, and other tools or single-use solutions, which support root canal procedures; restorative products that include artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. It also provides small equipment products, which comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was founded in 1877 and is headquartered in Charlotte, North Carolina.
Price of XRAY
XRAY FAQ
When is XRAY's latest earnings report released?
The most recent financial report for Dentsply sirona inc. (XRAY) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating XRAY's short-term business performance and financial health. For the latest updates on XRAY's earnings releases, visit this page regularly.
What is the operating profit of XRAY?
According to the latest financial report, Dentsply sirona inc. (XRAY) reported an Operating Profit of 63M with an Operating Margin of 7.17% this period, representing a growth of 50% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is XRAY's revenue growth?
In the latest financial report, Dentsply sirona inc. (XRAY) announced revenue of 879M, with a Year-Over-Year growth rate of -7.76%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does XRAY have?
As of the end of the reporting period, Dentsply sirona inc. (XRAY) had total debt of 2.42B, with a debt ratio of 0.4. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does XRAY have?
At the end of the period, Dentsply sirona inc. (XRAY) held Total Cash and Cash Equivalents of 398M, accounting for 0.07 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does XRAY go with three margins increasing?
In the latest report, Dentsply sirona inc. (XRAY) achieved the “three margins increasing” benchmark, with a gross margin of 53%%, operating margin of 7.17%%, and net margin of 2.3%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess XRAY's profit trajectory and future growth potential.
Is XRAY's EPS continuing to grow?
According to the past four quarterly reports, Dentsply sirona inc. (XRAY)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.1. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.
What is the FCF of XRAY?
Dentsply sirona inc. (XRAY)'s Free Cash Flow (FCF) for the period is -11M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 22.22% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of XRAY?
The latest valuation data shows Dentsply sirona inc. (XRAY) has a Price-To-Earnings (PE) ratio of -3.49 and a Price/Earnings-To-Growth (PEG) ratio of -0.36. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.